Skip to main content
. 2021 Apr 30;8:667776. doi: 10.3389/fmed.2021.667776

Table 1.

Descriptive results of potential risk factors and outcomes.

Variables Overall (n = 431) XDR-AB Colonized (n = 77) Not XDR-AB Colonized (n = 354) P-value
Age (years), median (IQR) 60.15 (49, 72) 60.36 (50.5, 71.5) 60.11 (49, 73) 0.919
Male, n (%) 292 (67.7) 56 (72.7) 236 (66.7) 0.302
Season, n (%)
Spring 147 (34.1) 24 (31.2) 123 (34.7) 0.907
Summer 103 (23.9) 18 (23.4) 85 (24.0) 0.811
Autumn 75 (17.4) 15 (19.5) 60 (16.9) 0.497
Winter 106 (24.6) 20 (26.0) 86 (24.3) 0.599
Charlson Index, mean ± SD 4.22 ± 2.146 4.52 ± 2.180 4.16 ± 2.136 0.181
Comorbidities, n (%)
Cardiovascular diseases 166 (38.5) 41 (53.2) 125 (35.3) 0.003
Chronic renal insufficiency 61 (14.2) 10 (13.0) 51 (14.4) 0.746
COPD 95 (22.0) 24 (31.2) 71 (20.1) 0.033
Type II diabetes mellitus 101 (23.4) 28 (36.4) 73 (20.6) 0.003
Solid tumor 106 (24.6) 10 (13.0) 96 (27.1) 0.009
Hematologic malignancy 8 (1.9) 2 (2.6) 6 (1.7) 0.595
Current or former smoker 160 (37.1) 35 (45.5) 125 (35.3) 0.095
Admission source, n (%)
Emergency department 110 (25.5) 17 (22.1) 93 (26.3) 0.178
Operation theater 106 (24.6) 18 (23.4) 88 (24.9) 0.936
Normal wards 126 (29.2) 19 (24.7) 107 (30.2) 0.761
Other hospital 89 (20.6) 23 (29.9) 66 (18.6) 0.072
Primary reason for ICU admission, n (%)
Neurological 53 (12.3) 5 (6.5) 48 (13.6) 0.087
Suspected sepsis 101 (23.4) 28 (36.4) 73 (20.6) 0.003
Respiratory 129 (29.9) 25 (32.5) 104 (29.4) 0.592
Cardiovascular (excluding stroke) 65 (15.1) 11 (14.3) 54 (15.3) 0.830
Multiple trauma 25 (5.8) 3 (3.9) 22 (6.2) 0.430
Burns 7 (1.6) 3 (3.9) 4 (1.1) 0.082
Hepatobiliary and pancreatic 21 (4.9) 0 (0.0) 21 (5.9) 0.028
Gastrointestinal 19 (4.4) 1 (1.3) 18 (5.1) 0.142
Genitourinary 11 (2.6) 1 (1.3) 10 (2.8) 0.442
APACHE II score, mean ± SD 15.278 ± 8.837 19.273 ± 8.871 15.409 ± 8.600 <0.001
Intensity of care, n (%)
Renal replacement therapy 71 (16.5) 20 (26.0) 51 (14.4) 0.013
Invasive ventilation for more than 5 days 209 (48.5) 64 (83.1) 145 (41.0) <0.001
Vasopressor treatment for more than 3 days 100 (23.2) 28 (36.4) 72 (20.3) 0.003
XDR-AB infection, n (%) 30 (7.0) 17 (22.1) 13 (3.7) <0.001
Clinical outcomes
Length of stay in ICU, median (IQR) 18.85 (3, 83) 28.58 (3,76) 16.74 (3,83) <0.001
28-day mortality, n (%) 67 (15.5) 12 (15.6) 55 (15.5) 0.992
Six-month mortality, n (%) 207 (48.0) 53 (68.8) 154 (43.5) <0.001

Data are number (%), median (IQR), or mean ± SD. XDR-AB, extensively drug-resistant Acinetobacter baumannii; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation; IQR, interquartile range; SD, standard deviation.